期刊文献+

抗癌新药伊立替康含量测定方法的研究 被引量:4

Studies on Determination of New Anticancer Drug Irinotecan
下载PDF
导出
摘要 目的 :建立反相高效液相色谱法测定抗癌新药伊立替康的含量。方法 :采用外标法 ,色谱柱为AlltimaC18柱 ( 5μm ,2 50mm× 4 6mm) ;流动相为乙腈 -pH 4 0的 0 1mol·L- 1磷酸氢二钾缓冲液 ( 2 58∶74 2 ,含 2 5 7mmol·L- 1三乙胺 ) ;检测波长为 2 54nm ;流速为 1 0mL·min- 1。结果 :伊立替康浓度与峰面积具有良好相关性 ,线性范围为 1 96~ 9 80 μg·mL- 1,r =0 9998,精密度RSD为 0 73 % ,平均回收率为 ( 99 83± 0 95) % ,最低检测限为 1 0ng·mL- 1。结论 :该方法灵敏 ,准确 。 Objective:RP-HPLC methods were developed for the determination of Irinotecan,a water soluble derivative of camptothecin,with potent anticancer activity Method:An Alltima C 18 column was used and a UV detector was set at 254 nm The mobile phase was a mixture of acetonitrile-0 1 mol·L -1 phosphate buffer solution(pH 4 0)containing 25 6 mmol·L -1 triethylamine(258∶742) The flow rate was 1 0 mL·min -1 Results:The linear range was 1 96~9 80 μg·m -1 and the correlation coefficient was 0 999 8,the RSD of injection was 0 73%,the average recovery of the method was 99 83%,the lower limit of determination was 10 ng·mL -1 Conclusion:The method is accurate,sensitive and reliable
出处 《药物分析杂志》 CAS CSCD 北大核心 1999年第5期293-296,共4页 Chinese Journal of Pharmaceutical Analysis
关键词 抗癌药 新药 伊立替康 含量 测定 Irinotecan,RP-HPLC
  • 相关文献

同被引文献32

  • 1林克江,李玉艳,尤启冬,林怡斌,张之磊.喜树碱代谢活性产物SN-38类似物的抗肿瘤构效关系研究[J].中国药科大学学报,2006,37(3):218-221. 被引量:7
  • 2李宝齐,邓英杰,杨静文.超滤-HPLC法测定盐酸拓扑替康脂质体包封率[J].中国新药杂志,2007,16(1):58-61. 被引量:15
  • 3杨建坤,商亚贞,刘宏伟,王志田,薛桂花.盐酸伊立替康的药理特性及临床应用[J].河北职工医学院学报,2007,24(1):61-62. 被引量:13
  • 4Nicola F. Smith, William D, Figg Alex Sparreboom. Pharmacogenetics of irinotecan metabolism and transport : An update. Toxicol in Vitro, 2006 ( 20 ) : 163.
  • 5PINGQi-neng(平其能).Modem Phannaceutics(现代药剂学),Beijing(北京):ChinaMedico-Pharmaceutical Scienceand Technology Publishing House(中国医药科技出版社),1998.608.
  • 6Gregor lad, Is G. Liposome Technology Volume I, Liposome Preparation and Related Techniques. Second edition. London, England: CRC press, 1993:585.
  • 7Paul G. Tardi, Ryan C, Gallaghera, et al. Coencapsulation of irinotecan and floxuridine into low cholesterol - containing liposomes that coordinate drug release in vivo. Bioehimica et Biophysica Acta ,2007:678.
  • 8Oh Ws, Park HY. Improvement of permeate flux by turbulence promot- er and development of mass transfer correlation in UF. Off Proc Comb 6^th Conf Asia Pae Confed Chem Eng 21st Australias. Chem Eng conf, 1993,1:359.
  • 9ChP(中国药典).2010.VolⅡ(二部):922.
  • 10Tsuruo T, Matsuzaki T, Matsushita M, et al. Antitumor effect of CPT-11, a new derivative of camptothecin, against pleiotropic drug-resistant tumors in vitro and in vivo[J]. Cancer Chemother Pharmacol, 1988,21 (1) : 71-74.

引证文献4

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部